Effect of arsenic trioxide on human hepatoma cell line BEL-7402 cultured in vitro

World Journal of Gastroenterology

Volumn 6, Issue 5, 2000, Pages 681-687

  Xu, H Y ^a   Yang, Y L ^a   Gao, Y Y ^a   Wu, Q L ^a   Gao, G Q ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; DNA; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG INHIBITION; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; MORPHOLOGY; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY;

EID: 0033787018     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v6.i5.681     Document Type: Article

References (58)

1. 72 Acute promyelocytic leukemia treated with arsenic trioxide
2. The PML and PML/RAR alpha domains: From autoimmunity to molecular oncology and from retinoic acid to arsenic
3. Testicular toxicity evaluation of arsenic-containing binary compound semiconductors, gallium arsenide and indium arsenide, in hamsters
4. Development of arsenical clinical application and study of arsenical mechanism
5. 3 exerts dose-dependent dual effects on APL cells
6. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines
7. Application of human cancer cells cultured in vitro on cancer study
8. 3
9. Study on the apoptosis and cell cycle arrest in human liver cancer SMMC7721 cells induced by Jianpiliqi herbs
10. Induction of arsenic trioxide on apoptosis of hepatocarcinoma cell lines
11. Proliferation inhibition and apoptosis induction by arsenic trioxide on gastric cancer cell SGC-7901
12. Cell apoptosis and neoplasms
13. Apoptosis of hepatocyte and precancerous lesion of hepatocellular carcinoma
14. Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma
15. Apoptosis in human hepatocellular carcinoma by terminal deoxynucleotidyl transferase-mediate dUTP-FITC nick end labeling
16. 3 exerts dose-dependent dual effects on APL cells
17. Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines
18. FADD and TRADD expression and apoptosis in primary human hepatocellular carcinoma
19. Relationship between expression of apoptosis-related antigens in hepatocellular carcinoma and in situ end labeling
20. Oncoprotein expression and inhibition of apoptosis during colorectal tumorigenesis
21. Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells
22. Apoptosis induced by norcantharidin in human tumor cells
23. Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China
24. Gastric cancer and apoptosis
25. Progression apoptosis of neoplasm cell induce by drugs
26. Apoptosis of neoplasm cell lines induced by hepatic peptides extracted from sucking porcine hepatocytes
27. Bcl-2 heterodimer in vivo with a conserved homolog, Bax, that accelerates programmed cell death
28. Bad a heterodimeric partner for bcl-xl and bcl-2, displaces bax and promotes cell death
29. Expression of bcl-2 and c-myc protein in gastric carcinoma and precancerous lesions
30. Retrovirus-mediated antisense RNA to bcl-2 alter the biological behavior of stomach carcinoma MGC-803 cell lines
31. Presence of Fas and Bcl-2 proteins in BEL-7404 human hepatoma cells
32. Apoptosis and expression of bcl-2 gene in gallbladder neoplasms
33. Apoptosis, Bcl-2 and P53 protein expressions in tissues from hepatocellular carcinoma
34. The role of bcl-2 gene in apoptosis of liver in rat with obstructive jaundice
35. Expression and significance of apoptosis related gene bcl-2, bax in human large intestine adenocarcinoma
36. Relationship between C-myc and Bcl-2 alterations and biological behavior and apoptosis in gastric cancer
37. The study of the expression of Bcl-2 and Bax in hepatocellular carcinoma
38. Overexpression of Bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
39. Bcl-2 is an inner mitochondrial membrane protein that programmed cell death
40. Bcl-2 deregulation leads to inhibition of sodium butyrate-induced apoptosis in human colorectal carcinoma cells
41. Bik, a novel death-inducing protein, shares a distinct sequence motif with bcl-2 family proteins and interacts with viral and cellular survival- promoting proteins
42. Cell death in health and disease, the biology and regulation of apoptosis
43. Analysis of the role of bcl-2 in apoptosis
44. Bcl-2: An antidote to programmed cell death
45. Bcl-2 and the regulation of programmed cell death
46. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor deprived hematopoietic cell lines
47. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
48. Constitutive expression of human Bcl-2 modulates nitrogen mustard and campothecin-induced apoptosis
49. Expression of bcl-2 protein in gastric carcinoma and its significance
50. Expression and significance of proapoptotic gene Bax in gastric carcinoma
51. Relationship between expression of apoptosis-related antigens in hepatocellular carcinoma and in situ end labeling
52. Angiogenesis and apoptosis in human hepatocellular carcinoma
53. Bax gene expression and its relationship with apoptosis in human gastric carcinoma and precancerous lesions
54. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARalpha/PML proteins
55. Acute promyelocytic leukemia: Cellular and molecular basis of differentiation and apoptosis
56. Lethal effect of the anti-Fas antibody in mice